A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors
Phase: Recruiting
Condition(s): Germ Cell Tumor
Other Study ID Number(s): AGCT1531
Who Can Take Part in This Study?
- Low Risk Stratum: Patients must be < 50 years of age at enrollment.
- Standard Risk 1: Patient must be < 11 years of age at enrollment.
- Standard Risk 2: Patients must be ≥ 11 and < 25 years of age at enrollment